Federal Official Gazette
No updates.
ANS news
No updates.
Open public consultations
- CP 167. Subject: CP opened to collect criticism and suggestions regarding the preliminary recommendations contained in UAT No. 186 – Encorafenib, UAT No. 189 – Osimertinib and UAT No. 190 – Talazoparib. Deadline: Feb 10 to Mar 1.
Scheduled public hearings
There are no scheduled public hearings.
Open public calls for input
- The Public Call for Input (TPS) is hereby opened, intended for receiving suggestions on the priority topics of Supplementary Health that will inform the composition of the 2026-2028 Regulatory Agenda of the National Supplementary Health Agency (Agência Nacional de Saúde Suplementar – ANS). Extension: February 27, 2026.
Open public calls
No updates.
Other news
STJ orders health plan that canceled contract proposal to pay for ableism
Source: nice.org.uk · read the full article
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.